Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead.
Tune in for an insightful discussion on the current biotech landscape and its impact on national security.
Key Topics
- Global Competition and U.S. Response
- Latest Developments and Innovations
- Challenges and Opportunities Ahead
- Geopolitical Influence
- Future Prospects and Potential Risks
Featured in this Episode
Farid Nemri
Program Manager
LinkedIn: https://www.linkedin.com/in/faridnemri/
Eugene Chiu
Senior Partner, Investments
LinkedIn - https://www.linkedin.com/in/eugenechiu
Dr. Michelle Rozo
VP Technology
LinkedIn - https://www.linkedin.com/in/michelle-rozo
Weitere Episoden von „The IQT Podcast“
Verpasse keine Episode von “The IQT Podcast” und abonniere ihn in der kostenlosen GetPodcast App.